PRA Health Sciences (PRAH) Tops Q1 EPS by 4c, Offers FY Guidance

Go back to PRA Health Sciences (PRAH) Tops Q1 EPS by 4c, Offers FY Guidance

PRA Health Sciences, Inc. Reports First Quarter 2019 Results

May 1, 2019 4:00 PM EDT

Net new business of $664.6 million; Net book-to-bill of 1.27$722.0 million of total revenue; representing 2.9% growth at actual foreign exchange rates and 4.4% growth on a constant currency basisGAAP net income per diluted share of $0.66 and GAAP net income of $44.1 millionAdjusted net income per diluted share was $1.10 and adjusted net income was $73.3 millionReaffirming 2019 guidance

RALEIGH, N.C., May 01, 2019 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (PRA, "we," "us" or the Company) (NASDAQ:... More